MR-guided focused ultrasound can safely deliver antibody therapy to Her2-positive brain metastases

By | October 14, 2021
In a first-in-world clinical trial, researchers at Sunnybrook Health Sciences Centre in Toronto, Canada, have demonstrated that magnetic resonance (MR)-guided focused ultrasound can be used to safely deliver antibody therapy to breast cancer that has metastasized to the brain.